Optiscan 2024 Roadshow Presentation
Filed with ASX · · 29 pages · English
Summary by 6ix AI
The presentation outlines the company's innovative technology in digital pathology and its applications in improving patient outcomes. It also discusses the significance of partnerships, including one with the Mayo Clinic, and the expected milestones in the coming months. This announcement serves to inform investors about Optiscan's growth and strategic direction in the medical technology sector.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Optiscan Imaging Limited on 6ix
In the deck
Earlier from Optiscan Imaging
- Optiscan Reveals InVue Imaging Device for Precision Surgery
- Optiscan Webinar Investor Presentation
- Optiscan Signs Know-How Agreement with Mayo Clinic
- OIL March 2024 Quarterly Report and Appendix 4C
- Optiscan appoints US Clinical & Regulatory Heads
Later from Optiscan Imaging
- Optiscan Receives Ethical Clearance for Breast Cancer Study
- Optiscan Delivers Major Milestone in Telepathology Platform
- OIL June 2024 Quarterly Report and Appendix 4C
- Optiscan Signs MOU with University of Minnesota
- Appendix 4E Preliminary Final Report
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging